XML 40 R22.htm IDEA: XBRL DOCUMENT v3.20.2
The Company and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2020
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
We measure the following financial instruments at fair value on a recurring basis. The fair values of these financial instruments were as follows (in thousands):
 
   
June 30, 2020
  
June 30, 2019
 
   
Level 1
   
Level 2
   
Level 3
  
Level 1
   
Level 2
   
Level 3
 
Warrant liability
  $—     $—     $(40,483 $—     $—     $(17,613
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
   
 
 
 
Total
  $—     $—     $(40,483 $—     $—     $(17,613
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
   
 
 
 
Schedule of Assumptions Used to Calculate Fair Value of Warrant Liability
To calculate the fair value of the warrant liability, the following assumptions were used:
 
   
June 30,
2020
  
June 30,
2019
 
Risk-free interest rate
   0.2  1.7
Expected life (years)
   2.9   3.8 
Expected volatility
   77.4  56.8
Dividend yield
   0.0  0.0
Black-Scholes Fair Value
  $2.52  $1.10 
Schedule of Changes in Estimated Fair Value of Warrant Liability
The following table sets forth a summary of changes in the estimated f
a
ir value of our Level 3 warrant liability for the years ended June 30, 2020 and 2019 (in thousands):
 
   
Fair Value of Warrants Using Significant
Unobservable Inputs (Level 3)
 
   
2020
   
2019
 
Balance at July 1,
  $17,613   $46,313 
Reclassification of derivative liability to equity upon exercise of warrants
   —      (1,068
Change in estimated fair value of liability classified warrants
   22,870    (27,632
  
 
 
   
 
 
 
Balance at June 30,
  $40,483   $17,613 
  
 
 
   
 
 
 
Schedule Of Revenue Associated With License Agreement
We recognized revenue associated with the following license agreements (in thousands):
 
   
Years Ended June 30,
 
   
2020
   
2019
   
2018
 
KKC Agreements
  $27,543   $2,557   $—   
Helsinn License Agreement
   1,370    2,358    1,622 
  
 
 
   
 
 
   
 
 
 
  $28,913   $4,915   $1,622 
  
 
 
   
 
 
   
 
 
 
Timing of Revenue Recognition:
      
License transferred at a point in time
  $
20,988
   $879   $—   
Services performed over time
   4,860    4,036    1,622 
Cumulative
catch-up
adjustment
   3,065    —      —   
  
 
 
   
 
 
   
 
 
 
   $28,913   $4,915   $1,622 
  
 
 
   
 
 
   
 
 
 
Schedule of Changes in Contract Assets and Contract Liabilities
The following table presents changes in contract assets and contract liabilities during the year ended June 30, 2020 and 2019 (in thousands):
 
   
Years Ended June 30,
 
   
2020
   
2019
 
Receivables
    
Receivables, beginning of year
  $—     $82 
Net change
   2,605    (82
  
 
 
   
 
 
 
Receivables, end of year
  $2,605   $—   
  
 
 
   
 
 
 
Contract assets
      
Contract assets, beginning of year
  $686   $312 
Net change
   (82   374 
  
 
 
   
 
 
 
Contract assets, end of year
  $604   $686 
  
 
 
   
 
 
 
Contract liabilities
      
Contract liabilities, beginning of year
  $7,774   $788 
Net change
   74,726    6,986 
  
 
 
   
 
 
 
Contract liabilities, end of year
  $82,500   $7,774 
  
 
 
   
 
 
 
Schedule of Income (Loss) Per Share, Basic and Diluted
The following table presents the calculation of net loss used to calculate basic and diluted loss per share (in thousands):
 
   
Years Ended June 30,
 
   
2020
   
2019
   
2018
 
Net loss—basic
  $(46,016  $(16,819  $(40,068
Change in fair value of warrant liability
   —      (37,794   —   
  
 
 
   
 
 
   
 
 
 
Net loss—diluted
  $(46,016  $(54,613  $(40,068
  
 
 
   
 
 
   
 
 
 
Calculation of Weighted Average Shares Used to Calculate Basic and Diluted (Loss) Earnings Per Share
Shares used in calculating net loss per share was determined as follows (in thousands):
 
   
Years Ended June 30,
 
   
2020
   
2019
   
2018
 
Weighted average shares outstanding
   91,080    71,139    41,064 
Effect of vested restricted stock units
   —      —      367 
  
 
 
   
 
 
   
 
 
 
Weighted average shares used in calculating net loss per share
   91,080    71,139    41,431 
Effect of potentially dilutive common shares from equity awards and liability-classified warrants
   —      1,246    —   
  
 
 
   
 
 
   
 
 
 
Weighted average shares used in calculating diluted loss per share
   91,080    72,385    41,431 
  
 
 
   
 
 
   
 
 
 
Antidilutive Securities
The following potentially dilutive shares (in thousands) that have been excluded from the calculation of net loss per share because of their anti-dilutive effect:
 
   
Years Ended June 30,
 
   
2020
   
2019
   
2018
 
Stock options
   11,030    8,057    5,606 
Restricted stock units
   —      32    336 
Warrants
   16,062    8,062    3,532 
  
 
 
   
 
 
   
 
 
 
Total anti-dilutive shares
   27,092    16,151    9,474